Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urinary Bladder, Neurogenic | 4 | 2023 | 173 | 1.130 |
Why?
|
Urinary Bladder, Overactive | 2 | 2021 | 115 | 0.820 |
Why?
|
Neuromuscular Agents | 2 | 2021 | 147 | 0.820 |
Why?
|
Varicocele | 1 | 2023 | 75 | 0.820 |
Why?
|
Synaptotagmin II | 1 | 2021 | 14 | 0.790 |
Why?
|
Synaptotagmin I | 1 | 2021 | 33 | 0.770 |
Why?
|
Botulinum Toxins, Type A | 2 | 2021 | 237 | 0.720 |
Why?
|
Spermatic Cord Torsion | 1 | 2020 | 72 | 0.690 |
Why?
|
Botulinum Toxins | 1 | 2021 | 189 | 0.680 |
Why?
|
Laparoscopy | 3 | 2024 | 2036 | 0.530 |
Why?
|
Cystectomy | 1 | 2019 | 634 | 0.460 |
Why?
|
Nerve Block | 1 | 2021 | 706 | 0.450 |
Why?
|
Reperfusion Injury | 1 | 2020 | 1023 | 0.440 |
Why?
|
Shiga-Toxigenic Escherichia coli | 2 | 2022 | 26 | 0.400 |
Why?
|
Hemolytic-Uremic Syndrome | 2 | 2022 | 106 | 0.380 |
Why?
|
Escherichia coli Infections | 2 | 2022 | 518 | 0.300 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2019 | 2223 | 0.270 |
Why?
|
Length of Stay | 2 | 2019 | 6426 | 0.260 |
Why?
|
Urinary Fistula | 1 | 2024 | 42 | 0.230 |
Why?
|
Urethral Diseases | 1 | 2024 | 52 | 0.230 |
Why?
|
Cutaneous Fistula | 1 | 2024 | 79 | 0.230 |
Why?
|
Hypospadias | 1 | 2024 | 97 | 0.220 |
Why?
|
Umbilical Cord | 1 | 2024 | 177 | 0.210 |
Why?
|
Scrotum | 1 | 2023 | 116 | 0.200 |
Why?
|
Urinary Bladder | 3 | 2014 | 1152 | 0.200 |
Why?
|
Sclerotherapy | 1 | 2023 | 182 | 0.190 |
Why?
|
Shiga Toxins | 1 | 2021 | 40 | 0.190 |
Why?
|
Trihexosylceramides | 1 | 2021 | 31 | 0.190 |
Why?
|
Fecal Incontinence | 1 | 2024 | 241 | 0.190 |
Why?
|
Gene Knock-In Techniques | 1 | 2021 | 421 | 0.170 |
Why?
|
Regeneration | 3 | 2014 | 1512 | 0.170 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2021 | 264 | 0.160 |
Why?
|
Urinary Diversion | 1 | 2019 | 134 | 0.150 |
Why?
|
Urography | 1 | 2019 | 316 | 0.150 |
Why?
|
Proteoglycans | 1 | 2021 | 803 | 0.150 |
Why?
|
Urologic Diseases | 1 | 2019 | 247 | 0.140 |
Why?
|
Testis | 1 | 2020 | 794 | 0.140 |
Why?
|
Urinary Tract | 1 | 2019 | 313 | 0.130 |
Why?
|
Spinal Cord Injuries | 1 | 2023 | 925 | 0.130 |
Why?
|
Antigens | 1 | 2021 | 1443 | 0.130 |
Why?
|
Bacterial Toxins | 1 | 2021 | 932 | 0.130 |
Why?
|
Atrophy | 1 | 2020 | 1633 | 0.120 |
Why?
|
Models, Animal | 1 | 2021 | 2112 | 0.120 |
Why?
|
Hernia, Inguinal | 1 | 2017 | 220 | 0.120 |
Why?
|
Nanofibers | 1 | 2014 | 66 | 0.120 |
Why?
|
Citrates | 2 | 2013 | 134 | 0.110 |
Why?
|
Clinical Protocols | 1 | 2019 | 1440 | 0.110 |
Why?
|
Multipotent Stem Cells | 1 | 2013 | 200 | 0.100 |
Why?
|
Ischemia | 1 | 2020 | 1883 | 0.100 |
Why?
|
Spinal Dysraphism | 1 | 2013 | 178 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1924 | 0.090 |
Why?
|
Elastomers | 1 | 2010 | 69 | 0.090 |
Why?
|
Citric Acid | 1 | 2010 | 123 | 0.090 |
Why?
|
Immunomodulation | 1 | 2013 | 549 | 0.080 |
Why?
|
Rats, Nude | 3 | 2014 | 105 | 0.080 |
Why?
|
Hospitals, Pediatric | 1 | 2017 | 1860 | 0.080 |
Why?
|
Bacterial Proteins | 1 | 2021 | 3847 | 0.070 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2013 | 499 | 0.070 |
Why?
|
Polymers | 2 | 2013 | 1617 | 0.070 |
Why?
|
Fetal Blood | 1 | 2013 | 1347 | 0.070 |
Why?
|
Muscle, Smooth | 1 | 2010 | 926 | 0.070 |
Why?
|
Animals | 8 | 2023 | 168467 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39107 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1809 | 0.060 |
Why?
|
Stem Cell Transplantation | 1 | 2013 | 1600 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5492 | 0.060 |
Why?
|
Urologic Surgical Procedures, Male | 1 | 2024 | 78 | 0.060 |
Why?
|
Child | 6 | 2024 | 80156 | 0.060 |
Why?
|
Postoperative Complications | 2 | 2024 | 15633 | 0.060 |
Why?
|
Colostomy | 1 | 2024 | 105 | 0.060 |
Why?
|
Enema | 1 | 2024 | 141 | 0.050 |
Why?
|
Humans | 15 | 2024 | 761572 | 0.050 |
Why?
|
Protein Conformation | 2 | 2021 | 3968 | 0.050 |
Why?
|
Myography | 1 | 2023 | 111 | 0.050 |
Why?
|
Bone Marrow Cells | 1 | 2010 | 2417 | 0.050 |
Why?
|
Male | 7 | 2024 | 360842 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2811 | 0.050 |
Why?
|
Tissue Scaffolds | 3 | 2014 | 934 | 0.050 |
Why?
|
Immunotoxins | 1 | 2021 | 175 | 0.040 |
Why?
|
Mice | 3 | 2023 | 81533 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2024 | 64684 | 0.040 |
Why?
|
Urodynamics | 1 | 2021 | 346 | 0.040 |
Why?
|
Mesenchymal Stem Cells | 1 | 2010 | 1642 | 0.040 |
Why?
|
Insulin Resistance | 1 | 2013 | 3963 | 0.040 |
Why?
|
Electric Impedance | 1 | 2023 | 757 | 0.040 |
Why?
|
Infant Care | 1 | 2019 | 180 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2021 | 650 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2021 | 3076 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2021 | 1120 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2013 | 5672 | 0.030 |
Why?
|
Infant | 3 | 2024 | 36192 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2023 | 22172 | 0.030 |
Why?
|
Body Weight | 1 | 2023 | 4618 | 0.030 |
Why?
|
Eating | 1 | 2019 | 1539 | 0.030 |
Why?
|
Binding Sites | 1 | 2021 | 6056 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1459 | 0.030 |
Why?
|
Rats | 3 | 2014 | 23741 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36429 | 0.020 |
Why?
|
Female | 7 | 2023 | 392686 | 0.020 |
Why?
|
Methyl Green | 1 | 2010 | 6 | 0.020 |
Why?
|
Models, Molecular | 1 | 2021 | 5439 | 0.020 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2010 | 69 | 0.020 |
Why?
|
Azo Compounds | 1 | 2010 | 117 | 0.020 |
Why?
|
Elastic Modulus | 1 | 2010 | 211 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2013 | 1341 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2024 | 80646 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 12148 | 0.020 |
Why?
|
Protein Binding | 1 | 2021 | 9353 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4948 | 0.020 |
Why?
|
Child, Preschool | 2 | 2024 | 42230 | 0.020 |
Why?
|
Adult | 2 | 2021 | 221203 | 0.020 |
Why?
|
Aged | 2 | 2019 | 169310 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2013 | 2115 | 0.020 |
Why?
|
Intestine, Small | 1 | 2014 | 1206 | 0.020 |
Why?
|
Nerve Regeneration | 1 | 2013 | 795 | 0.020 |
Why?
|
Middle Aged | 2 | 2019 | 220920 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2010 | 1085 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2010 | 2468 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14416 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2013 | 1349 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16592 | 0.020 |
Why?
|
Odds Ratio | 1 | 2017 | 9646 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2021 | 9177 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7407 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10553 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2014 | 3032 | 0.010 |
Why?
|
Tissue Engineering | 1 | 2013 | 1868 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2014 | 3066 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 7967 | 0.010 |
Why?
|
Collagen | 1 | 2010 | 2638 | 0.010 |
Why?
|
Neutrophils | 1 | 2014 | 3767 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18398 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2013 | 3085 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5791 | 0.010 |
Why?
|
Macrophages | 1 | 2014 | 5769 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 26198 | 0.010 |
Why?
|
Adolescent | 2 | 2017 | 88324 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 23996 | 0.010 |
Why?
|
Neoplasms | 1 | 2021 | 22173 | 0.010 |
Why?
|
United States | 1 | 2017 | 72335 | 0.010 |
Why?
|
Concepts
(140)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_